Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications
Recruiting
N/A
Interventional Study
Chronic Liver Disease and Cirrhosis
Liver Transplant; Complications
Donor Hepatectomy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 55
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 100 (estimated)
- Sponsor
- Institute of Liver and Biliary Sciences, India · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Living donor liver transplantation is widely accepted as an life-saving treatment for patients with end-stage liver diseases. Careful donor selection is essential to maximize the success and minimize the risk of postoperative complications in donors and recipients. Mapping of biliary anatomy is one of the critical assessments for donor selection and surgical planning ,Biliary reconstruction is con…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All prospective voluntary healthy liver donor of age 18-55
Exclusion Criteria:
* Type C/D Portal vein anatomy
* Left sided Gallbladder
* Right Posterior Graft
* Recipients undergoing Hepaticojejunostomy
Contacts
Dr Nilesh Sadashiv Patil, MCH
CONTACT